Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Marissa D. Zwan*, Femke H. Bouwman, Elles Konijnenberg, Wiesje M. van der Flier, Adriaan A. Lammertsma, Frans R. J. Verhey, Pauline Aalten, Bart N. M. van Berckel, Philip Scheltens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number2
Number of pages8
JournalAlzheimer's Research & Therapy
Volume9
DOIs
Publication statusPublished - 17 Jan 2017

Keywords

  • Alzheimer's disease
  • Dementia
  • Clinical practice
  • Diagnostic impact
  • Positron emission tomography
  • Imaging
  • Amyloid
  • PROGRESSIVE SUPRANUCLEAR PALSY
  • ALZHEIMERS-DISEASE
  • FRONTOTEMPORAL DEMENTIA
  • INTERNATIONAL WORKSHOP
  • NATIONAL INSTITUTE
  • DECISION-MAKING
  • CASE SERIES
  • BETA
  • CRITERIA
  • MANAGEMENT

Cite this

Zwan, M. D., Bouwman, F. H., Konijnenberg, E., van der Flier, W. M., Lammertsma, A. A., Verhey, F. R. J., ... Scheltens, P. (2017). Diagnostic impact of [18F]flutemetamol PET in early-onset dementia. Alzheimer's Research & Therapy, 9, [2]. https://doi.org/10.1186/s13195-016-0228-4
Zwan, Marissa D. ; Bouwman, Femke H. ; Konijnenberg, Elles ; van der Flier, Wiesje M. ; Lammertsma, Adriaan A. ; Verhey, Frans R. J. ; Aalten, Pauline ; van Berckel, Bart N. M. ; Scheltens, Philip. / Diagnostic impact of [18F]flutemetamol PET in early-onset dementia. In: Alzheimer's Research & Therapy. 2017 ; Vol. 9.
@article{276ce73eaef9488c914616e8466a4b2d,
title = "Diagnostic impact of [18F]flutemetamol PET in early-onset dementia",
keywords = "Alzheimer's disease, Dementia, Clinical practice, Diagnostic impact, Positron emission tomography, Imaging, Amyloid, PROGRESSIVE SUPRANUCLEAR PALSY, ALZHEIMERS-DISEASE, FRONTOTEMPORAL DEMENTIA, INTERNATIONAL WORKSHOP, NATIONAL INSTITUTE, DECISION-MAKING, CASE SERIES, BETA, CRITERIA, MANAGEMENT",
author = "Zwan, {Marissa D.} and Bouwman, {Femke H.} and Elles Konijnenberg and {van der Flier}, {Wiesje M.} and Lammertsma, {Adriaan A.} and Verhey, {Frans R. J.} and Pauline Aalten and {van Berckel}, {Bart N. M.} and Philip Scheltens",
year = "2017",
month = "1",
day = "17",
doi = "10.1186/s13195-016-0228-4",
language = "English",
volume = "9",
journal = "Alzheimer's Research & Therapy",
issn = "1758-9193",
publisher = "BioMed Central Ltd",

}

Zwan, MD, Bouwman, FH, Konijnenberg, E, van der Flier, WM, Lammertsma, AA, Verhey, FRJ, Aalten, P, van Berckel, BNM & Scheltens, P 2017, 'Diagnostic impact of [18F]flutemetamol PET in early-onset dementia', Alzheimer's Research & Therapy, vol. 9, 2. https://doi.org/10.1186/s13195-016-0228-4

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia. / Zwan, Marissa D.; Bouwman, Femke H.; Konijnenberg, Elles; van der Flier, Wiesje M.; Lammertsma, Adriaan A.; Verhey, Frans R. J.; Aalten, Pauline; van Berckel, Bart N. M.; Scheltens, Philip.

In: Alzheimer's Research & Therapy, Vol. 9, 2, 17.01.2017.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

AU - Zwan, Marissa D.

AU - Bouwman, Femke H.

AU - Konijnenberg, Elles

AU - van der Flier, Wiesje M.

AU - Lammertsma, Adriaan A.

AU - Verhey, Frans R. J.

AU - Aalten, Pauline

AU - van Berckel, Bart N. M.

AU - Scheltens, Philip

PY - 2017/1/17

Y1 - 2017/1/17

KW - Alzheimer's disease

KW - Dementia

KW - Clinical practice

KW - Diagnostic impact

KW - Positron emission tomography

KW - Imaging

KW - Amyloid

KW - PROGRESSIVE SUPRANUCLEAR PALSY

KW - ALZHEIMERS-DISEASE

KW - FRONTOTEMPORAL DEMENTIA

KW - INTERNATIONAL WORKSHOP

KW - NATIONAL INSTITUTE

KW - DECISION-MAKING

KW - CASE SERIES

KW - BETA

KW - CRITERIA

KW - MANAGEMENT

U2 - 10.1186/s13195-016-0228-4

DO - 10.1186/s13195-016-0228-4

M3 - Article

VL - 9

JO - Alzheimer's Research & Therapy

JF - Alzheimer's Research & Therapy

SN - 1758-9193

M1 - 2

ER -